Suppr超能文献

GATA3附近的一种基因变异与良性前列腺增生(BPH)和下尿路症状(LUTS)的遗传易感性及病因有关。

A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).

作者信息

Na Rong, Helfand Brian T, Chen Haitao, Conran Carly A, Crawford Susan E, Hayward Simon W, Tammela Teuvo L J, Hoffman-Bolton Judy, Zheng Siqun L, Walsh Patrick C, Schleutker Johanna, Platz Elizabeth A, Isaacs William B, Xu Jianfeng

机构信息

Program for Personalized Cancer Care, NorthShore University HealthSystem, Evanston, Illinois.

Fudan Institute of Urology, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Prostate. 2017 Aug;77(11):1213-1220. doi: 10.1002/pros.23380. Epub 2017 Jun 28.

Abstract

BACKGROUND

Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) are common conditions. Little is known about their etiologies except that studies have suggested a substantial heritable component. Our objective is to provide a comprehensive, genome-wide evaluation of inherited risks and possible mechanisms of etiology in BPH.

METHODS

We performed a three-stage, genome-wide association study (GWAS) of men from three independent populations, the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial, the CLUE II cohort, and a Finnish hospital-based population. DNA samples were genotyped using the Illumina HumanOmniExpress BeadChip in REDUCE and CLUE II, and using the Sequenom iPLEX system for the confirmation stage in the Finnish population. A logistic regression model was used to evaluate the association between each SNP and BPH/LUTS.

RESULTS

Fourteen SNPs reached P < 5.0 × 10 in the meta-analysis of the two GWASs (CLUE II and REDUCE). A total of 773 SNPs were chosen for the confirmation step in the Finish cohort. Only one SNP (rs17144046) located ∼489 kb downstream of GATA3 remained significant after correction for multiple testing (P < 6.5 × 10 ). This SNP marginally reached the GWAS significance level after performing a meta-analysis of the three stages (P  = 8.89 × 10 ). Expression quantitative trait loci (eQTL) analyses showed that the risk allele (G) of rs17144046 was significantly associated with increased expression of GATA3 (P = 0.017). Reported studies indicated a close correlation between GATA3 and BPH pathogenesis and progression.

CONCLUSIONS

Rs17144046 located near GATA3 was significantly associated with BPH/LUTS in three independent populations, but did not reach a stringent GWAS significance level. Genetic variants of GATA3 may play a role in the inherited susceptibility and etiology of BPH/LUTS. Further research in this area is needed.

摘要

背景

良性前列腺增生(BPH)及相关下尿路症状(LUTS)是常见病症。除了研究表明存在显著的遗传因素外,对其病因知之甚少。我们的目标是对BPH的遗传风险和可能的病因机制进行全面的全基因组评估。

方法

我们对来自三个独立人群的男性进行了三阶段全基因组关联研究(GWAS),这三个独立人群分别是度他雄胺降低前列腺癌事件(REDUCE)试验、CLUE II队列以及芬兰一个基于医院的人群。在REDUCE和CLUE II中,使用Illumina HumanOmniExpress BeadChip对DNA样本进行基因分型,在芬兰人群的验证阶段使用Sequenom iPLEX系统。使用逻辑回归模型评估每个单核苷酸多态性(SNP)与BPH/LUTS之间的关联。

结果

在两项GWAS(CLUE II和REDUCE)的荟萃分析中,14个SNP达到P < 5.0×10。总共选择了773个SNP在芬兰队列中进行验证步骤。经过多重检验校正后,只有一个位于GATA3下游约489 kb处的SNP(rs17144046)仍然显著(P < 6.5×10)。在对三个阶段进行荟萃分析后,这个SNP勉强达到GWAS显著性水平(P = 8.89×10)。表达数量性状基因座(eQTL)分析表明,rs17144046的风险等位基因(G)与GATA3表达增加显著相关(P = 0.017)。已发表的研究表明GATA3与BPH发病机制和进展密切相关。

结论

位于GATA3附近的rs17144046在三个独立人群中与BPH/LUTS显著相关,但未达到严格的GWAS显著性水平。GATA3的基因变异可能在BPH/LUTS的遗传易感性和病因中起作用。该领域需要进一步研究。

相似文献

2
Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.
Eur Urol. 2014 Oct;66(4):752-68. doi: 10.1016/j.eururo.2014.01.007. Epub 2014 Jan 22.

引用本文的文献

1
Identification of novel plasma proteins as potential therapeutic targets for benign prostatic hyperplasia: a proteome-wide association study.
Transl Androl Urol. 2025 Jun 30;14(6):1679-1690. doi: 10.21037/tau-2025-187. Epub 2025 Jun 23.
3
Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?
Eur Urol Open Sci. 2024 Oct 31;70:154-157. doi: 10.1016/j.euros.2024.10.012. eCollection 2024 Dec.
4
Inheritance patterns of lower urinary tract symptoms in adults: a systematic review.
BJU Int. 2025 Feb;135(2):192-203. doi: 10.1111/bju.16517. Epub 2024 Aug 26.
6
Japanese giant benign prostatic hyperplasia: Sibling cases.
IJU Case Rep. 2022 May 9;5(4):312-314. doi: 10.1002/iju5.12467. eCollection 2022 Jul.
7
Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea.
Int Neurourol J. 2021 Dec;25(4):347-354. doi: 10.5213/inj.2040412.206. Epub 2021 Jan 27.
8
Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk.
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):492-498. doi: 10.1038/s41391-020-00303-2. Epub 2020 Nov 20.
9
Single-Nucleotide Polymorphism-Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis.
JAMA Netw Open. 2019 Dec 2;2(12):e1918145. doi: 10.1001/jamanetworkopen.2019.18145.
10
Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.
Medicines (Basel). 2019 Jul 30;6(3):82. doi: 10.3390/medicines6030082.

本文引用的文献

1
The essential role of GATA transcription factors in adult murine prostate.
Oncotarget. 2016 Jul 26;7(30):47891-47903. doi: 10.18632/oncotarget.10294.
2
Heritability of Lower Urinary Tract Symptoms in Men: A Twin Study.
J Urol. 2016 Nov;196(5):1486-1492. doi: 10.1016/j.juro.2016.06.018. Epub 2016 Jun 14.
3
Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.
World J Urol. 2017 Feb;35(2):293-298. doi: 10.1007/s00345-016-1869-4. Epub 2016 Jun 8.
4
A Population-Based Study on the Association between Benign Prostatic Enlargement and Rheumatoid Arthritis.
PLoS One. 2015 Jul 14;10(7):e0133013. doi: 10.1371/journal.pone.0133013. eCollection 2015.
5
Association of variants in genes related to the immune response and obesity with BPH in CLUE II.
Prostate Cancer Prostatic Dis. 2014 Dec;17(4):353-8. doi: 10.1038/pcan.2014.36. Epub 2014 Sep 16.
7
Pathophysiology of allergic inflammation.
Immunol Rev. 2011 Jul;242(1):31-50. doi: 10.1111/j.1600-065X.2011.01020.x.
8
PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.
Differentiation. 2011 Nov-Dec;82(4-5):220-36. doi: 10.1016/j.diff.2011.05.008. Epub 2011 Jun 8.
9
Association of IL10, IL10RA, and IL10RB polymorphisms with benign prostate hyperplasia in Korean population.
J Korean Med Sci. 2011 May;26(5):659-64. doi: 10.3346/jkms.2011.26.5.659. Epub 2011 Apr 21.
10
GWAMA: software for genome-wide association meta-analysis.
BMC Bioinformatics. 2010 May 28;11:288. doi: 10.1186/1471-2105-11-288.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验